Core Points - Vanguard Mining Corp. has successfully closed a non-brokered private placement of 2,933,267 flow-through units at a price of $0.15 per unit, resulting in gross proceeds of $439,990.05 [1] - Each flow-through unit consists of one common share and one-half of a common share purchase warrant, with the warrants exercisable at $0.22 for 18 months [1] - The proceeds from the offering will be used for exploration expenditures on resource claims in British Columbia, qualifying as "Canadian exploration expenses" [3] Company Insights - David Greenway, CEO of Vanguard, expressed optimism about the financing and the company's position to unlock significant value through its uranium and critical mineral projects [2] - The company is focused on the discovery and development of high-value strategic minerals, particularly uranium, in the U.S. and Paraguay [5] - Vanguard is committed to responsible exploration and aims to advance its highly prospective uranium properties [5]

Core Viewpoint - Pambili Natural Resources Corporation has secured C$138,500 as the first tranche of a C$1-million non-brokered private placement, aimed at supporting its operations and financial reporting requirements [1][4]. Funding Details - The first tranche consists of 2,770,000 Units, each priced at C$0.05, which includes one common share and one warrant with an exercise price of C$0.10, valid for one year [2][3]. - The total proceeds from the tranche will be allocated to various expenses, including C$90,000 for audit fees, C$15,000 for accounting fees, C$15,000 for legal fees, C$8,500 for filing fees, and C$10,000 for general and administrative costs [4]. Regulatory Context - The company is currently under a Failure to File Cease Trade Order (FFCTO) issued by the Alberta Securities Commission, and it has applied for a partial revocation to facilitate the closing of the tranche [2][4]. - The completion of the offering is contingent upon the approval from the Alberta Securities Commission and the TSX Venture Exchange [2][4]. Management Commentary - The CEO of Pambili expressed optimism regarding the company's gold projects in Zimbabwe, highlighting the potential for growth in the current high gold price environment [5].

Core Viewpoint - Lexaria Bioscience Corp. will participate in the 27th Annual H.C. Wainwright Global Investment Conference from September 8th to September 10th, 2025, highlighting its innovative drug delivery technology, DehydraTECH [1][3]. Company Overview - Lexaria Bioscience Corp. is a global innovator in drug delivery platforms, focusing on improving the way drugs enter the bloodstream through oral delivery [1][3]. - The company operates a licensed in-house research laboratory and holds a strong intellectual property portfolio with 50 patents granted and additional patents pending worldwide [3]. Technology Highlights - DehydraTECH™ is Lexaria's patented drug delivery formulation and processing platform that enhances bio-absorption, reduces side effects, and improves drug delivery across the blood-brain barrier [3].

Core Insights - New Age Metals Inc. (NAM) has reported promising assay results for antimony and gold from its properties in Newfoundland and Labrador, indicating significant mineralization potential [1][3][4] - The company is currently conducting Phase 2 exploration work following a successful Phase 1 program, which confirmed the presence of high-grade antimony and gold mineralization [1][3][4] Phase 1 Highlights - A total of 286 grab samples were collected, with notable results including up to 15.2% Sb and 1.52 g/t Au, indicating a robust multi-metal system [2][3][4] - The antimony price surged to over $60,000 per tonne due to China's export restrictions, creating a supply shock for this critical metal [2][30][31] Mineralization Potential - The St Alban's area properties are highly prospective for Au–Sb mineralization, with a newly identified ~16 km trend extending from various occurrences [3][4][6] - Significant assay results include: - 15.2% Sb from Antimony Ridge - 1.52 g/t Au from the Citadel Property - 131 g/t Ag and 29.3% Pb from the Fort Property [4][5][6] Beaver Brook Area Properties - The Beaver Brook Area properties are geologically significant, hosting potential for both Sb and Au systems, consistent with the broader mineralizing environment [6][7] - New discoveries in the Beaver Brook Area include elevated gold values and significant mineralization potential [8][6] Market Dynamics - The antimony market is heavily influenced by geopolitical factors, with approximately 70% of production occurring in China [30][31] - Gold prices have reached historical highs, driven by increased demand from central banks and retail investors amid economic uncertainties [30][31] Strategic Positioning - NAM's properties cover approximately 20,000 hectares, strategically located along mineralized trends associated with past-producing mines [32][33] - The Province of Newfoundland and Labrador has been recognized as a top-10 mining jurisdiction, enhancing the attractiveness of NAM's exploration efforts [33]

Core Viewpoint - Inflection Resources Ltd. has been granted several exploration licenses in the northern extension of the Molong Volcanic Belt, which the company believes to be highly prospective for large copper-gold intrusive related mineral systems [1][2]. Summary by Sections Exploration Licenses - The company has acquired 3,336 km² of exploration licenses, referred to as the Molong North project, which includes two main areas: Coonamble and Mendooran [3][5]. - These licenses cover large copper-gold targets that have never been drill tested and are strategically located north of the Cadia copper-gold mine owned by Newmont [5]. Geological Interpretation - The licenses are based on detailed geological interpretation that models the extension of the Macquarie Arc further north, under post-mineral cover [2][4]. - The company utilized precompetitive geological and geophysical data to identify intrusion-like anomalies in the Ordovician basement, which may represent large porphyry or intrusion-related copper-gold systems [4][5]. Target Areas - Eleven major targets have been identified in the Coonamble area, showing high amplitude magnetic signatures indicative of potential porphyry-related alteration at depth [7][8]. - The Mendooran target area consists of interpreted intrusions along a significant cross-arc structure, which is important for fluid flow and the emplacement of large-scale mineral systems [12][14]. Exploration Strategy - The company plans to explore these new areas with a methodical and cost-effective approach, applying sound geoscience [2][5]. - Inflection has significant experience exploring the covered segment of the Macquarie Arc and has an ongoing exploration partnership with AngloGold Ashanti [4][5].

Group 1 - The Corporation, Newlox Gold Ventures Corp., is currently unable to file its audited financial statements for the fiscal year ended March 31, 2025, by the deadline of July 29, 2025, due to a management change and difficulties in obtaining necessary documents from Costa Rica for the audit [1][3] - A management cease trade order (MCTO) was issued by the British Columbia Securities Commission on July 30, 2025, prohibiting the Chief Executive Officer and Chief Financial Officer from trading in the Corporation's securities until the required filings are completed [2] - The Corporation has committed to providing bi-weekly default status reports in accordance with National Policy 12-203 while it remains in default of the filing requirements [5] Group 2 - Newlox Gold Ventures Corp. is focused on the recovery of gold and silver from artisanal and small-scale mining operations across Latin America, utilizing technology to recover precious metals and contribute to local economic development [6]

Core Viewpoint - Stellar AfricaGold Inc. has successfully completed drill hole TCK-001 at the Tichka Est Gold Project in Morocco, confirming the geological model and anticipating assay results to validate gold potential [1][5]. Drill Program Details - Drill hole TCK-001 was completed to a total depth of 225 meters as part of a 1,500-meter summer diamond drill program at Zone B, covering an area of approximately one square kilometer within the 82 km² Tichka Est Gold Project [2]. - The drilling intersected multiple horizons of fractured diorite between depths of 82 meters and 176 meters, including significant intervals of diorite sill [4]. Geological Findings - Observations from drill hole TCK-001 indicate potential mineralization is predominantly vein-hosted and fracture-controlled, with subvertical quartz ± sulphide veins [4]. - The geological features observed are consistent with those reported in surface trenches where gold mineralization was previously identified [4]. Sample Preparation and Assays - All mineralized intervals from TCK-001 have been logged and marked for sampling, with the first batch of samples expected to be dispatched to Afrilab for assay results anticipated in September [3]. Performance Share Units Granted - The company granted 650,000 Performance Share Units (PSUs) to Dr. Paul Kitto, contingent upon achieving a total of 600,000 ounces of Inferred and Indicated gold resources [5][6]. - Each PSU allows the holder to acquire one common share of the company upon meeting specific performance conditions [6]. Project Overview - The Tichka Est Gold Project consists of seven permits covering an area of 82 km² located in the High Atlas region of Morocco, approximately 90 km south of Marrakech [9]. - Under an earn-in agreement, the company can earn an 85% interest after incurring exploration expenditures totaling US$2.39 million (C$3.5 million) over three years [9]. Exploration Progress - Early-stage exploration has identified three gold-bearing zones, with additional regional sampling revealing numerous anomalous metal zones warranting further investigation [11].

Core Insights - Nord Precious Metals Mining Inc. has identified high-grade silver, gold, and critical metals mineralization across an extensive vein network at the Castle East location on the Castle Silver Mine property, following a comprehensive review by Ronacher McKenzie Geoscience [1][2] Exploration and Technical Update - The company has established a high-grade mineralized zone within 2 kilometers of the last operating high-grade silver mine in the Cobalt area, identifying 29 veins through advanced modeling techniques [2][6] - The review included over 75,000 meters of drill data, which has significantly enhanced the understanding of the potential scale of the Castle East property [2][6] Future Plans - The company plans to commence drilling in the fall to further define and increase confidence in the structural modeling, aiming for an updated Resource Estimate [3] Key Highlights - Twenty-nine veins have been identified, with 21 modeled in Area A and 8 in Area B, confirming a localized stockwork system [6] - The model validates previously reported exceptional grades, positioning Castle East among the highest-grade silver discoveries globally [6][7] Company Overview - Nord Precious Metals operates the only permitted high-grade milling facility in the historic Cobalt Camp of Ontario, with a flagship property encompassing 63 square kilometers [7] - The Castle East discovery has delineated 7.56 million ounces of silver in Inferred resources, averaging 8,582 g/t Ag from two sections of the Robinson Zone [7] Strategic Positioning - The company's integrated processing strategy supports the recovery of high-grade silver and critical minerals, including cobalt and nickel, leveraging established infrastructure [8] - Nord maintains a strategic portfolio of battery metals properties, including a 35% ownership in Coniagas Battery Metals Inc. and the St. Denis-Sangster lithium project [9]

Core Insights - Ocumetics Technology Corp. has successfully completed the one-week postoperative examination of the first patients implanted with the Ocumetics Accommodating Intraocular Lens, with all patients recovering well and no complications observed [1][3] - The company is now recruiting additional individuals to complete the first group of patients for the Ocumetics Lens [2] - The Ocumetics Lens aims to redefine vision correction by allowing the eye's natural muscular activity to focus on both distant and near objects without the need for glasses or contact lenses after cataract surgery [3][5] Company Overview - Ocumetics Technology Corp. is a Canadian research and product development company focused on advanced vision correction solutions to enhance patients' quality of life [4] - The company is dedicated to transforming the field of ophthalmology through innovative research and development of state-of-the-art intraocular lenses and other vision-enhancing technologies [4] Product Development - The Ocumetics Lens is designed to fit within the natural lens compartment of the eye, potentially eliminating the need for corrective lenses by providing clear vision at all distances [5] - The company is currently in the preclinical study phase for this groundbreaking technology in the ophthalmic industry [5]

Core Viewpoint - Ventripoint Diagnostics Ltd. is conducting a non-brokered private placement to raise up to CDN$500,000 through unsecured convertible debenture units, which will be convertible into common shares and include purchase warrants [1][2]. Group 1: Offering Details - The offering consists of unsecured convertible debenture units, with each unit having a principal amount of $1,000 convertible into common shares at a price of $0.11 per share [1][2]. - Each unit will also include 9,000 common share purchase warrants, allowing the holder to purchase shares at $0.14 until December 31, 2027 [1][2]. - The debentures will mature on December 31, 2027, and will bear an interest rate of 10%, payable semi-annually either in cash or in common shares at a 20-day VWAP market price [3]. Group 2: Use of Proceeds - The proceeds from the offering will be utilized for operational costs related to sales and marketing, hiring additional key personnel, and general working capital purposes [5]. Group 3: Securities and Compliance - All securities issued will be subject to a hold period of four months plus one day from the closing date of the offering, and the offering is subject to approval by the TSXV [6]. - The securities will not be registered under the U.S. Securities Act of 1933 and cannot be offered or sold in the United States without proper registration or exemption [7]. Group 4: Insider Transactions and Other Issuances - The corporation has issued 564,473 common shares to settle $76,203.59 of debenture interest, with shares subject to a hold period [8]. - An insider transaction involved the issuance of 50,042 shares, which is considered a related party transaction under MI 61-101, relying on exemptions due to the transaction's market capitalization not exceeding 25% [9]. - The corporation has also issued 6,000 common shares related to the exercise of broker's warrants and 200,000 options exercised at $0.11, both subject to a hold period [10][11]. Group 5: Advisory Agreement - An advisory agreement with Fournel Advisory includes a total consideration of 265,000 options exercisable at $0.11 per share and a cash payment of USD $30,000 [12]. Group 6: Company Overview - Ventripoint has established itself as a leader in applying AI to echocardiography, with its VMS+ products providing accurate cardiac measurements comparable to MRI, supported by regulatory approvals in the U.S., Europe, and Canada [14].